- Home
- TIVC vs INM Comparison
TIVC vs INM Comparison
Compare TIVC & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIVC
- INM
- Stock Information
- Founded
- TIVC 2016
- INM 1981
- Country
- TIVC United States
- INM Canada
- Employees
- TIVC N/A
- INM N/A
- Industry
- TIVC Biotechnology: Electromedical & Electrotherapeutic Apparatus
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- TIVC Health Care
- INM Health Care
- Exchange
- TIVC Nasdaq
- INM Nasdaq
- Market Cap
- TIVC 2.1M
- INM 2.3M
- IPO Year
- TIVC 2021
- INM N/A
- Fundamental
- Price
- TIVC $4.87
- INM $2.10
- Analyst Decision
- TIVC
- INM
- Analyst Count
- TIVC 0
- INM 0
- Target Price
- TIVC N/A
- INM N/A
- AVG Volume (30 Days)
- TIVC 1.8M
- INM 16.7K
- Earning Date
- TIVC 03-21-2025
- INM 05-13-2025
- Dividend Yield
- TIVC N/A
- INM N/A
- EPS Growth
- TIVC N/A
- INM N/A
- EPS
- TIVC N/A
- INM N/A
- Revenue
- TIVC $780,000.00
- INM $4,832,013.00
- Revenue This Year
- TIVC N/A
- INM N/A
- Revenue Next Year
- TIVC N/A
- INM N/A
- P/E Ratio
- TIVC N/A
- INM N/A
- Revenue Growth
- TIVC N/A
- INM N/A
- 52 Week Low
- TIVC $2.43
- INM $1.99
- 52 Week High
- TIVC $31.45
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- TIVC 58.60
- INM 28.06
- Support Level
- TIVC $2.43
- INM $1.99
- Resistance Level
- TIVC $3.58
- INM $2.14
- Average True Range (ATR)
- TIVC 0.51
- INM 0.15
- MACD
- TIVC 0.18
- INM -0.05
- Stochastic Oscillator
- TIVC 72.40
- INM 12.09
About TIVC Tivic Health Systems Inc.
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.